US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 0.909
  • +0.039+4.46%
Close May 28 16:00 ET
12.92MMarket Cap-590P/E (TTM)

Chemomab Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: May 13, 2024

Based on 2 analysts giving stock ratings to Chemomab Therapeutics in the past 3 months

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: May 13, 2024

The average Chemomab Therapeutics stock price target is 5.00 with a max estimate of 6.00 and a min estimate of 4.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: May 13, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: May 13, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg